Mycobacterium tuberculosis Sulfolipid-1 Activates Nociceptive Neurons and Induces Cough
Author(s) -
Cody R. Ruhl,
Breanna L. Pasko,
Haaris Khan,
Lexy M. Kindt,
Chelsea E. Stamm,
Luis H. Franco,
Connie C. W. Hsia,
Min Zhou,
Colton R. Davis,
Tian Qin,
Laurent Gautron,
Michael D. Burton,
Galo L. Mejia,
Dhananjay K. Naik,
Gregory Dussor,
Theodore J. Price,
Michael U. Shiloh
Publication year - 2020
Publication title -
cell
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 26.304
H-Index - 776
eISSN - 1097-4172
pISSN - 0092-8674
DOI - 10.1016/j.cell.2020.02.026
Subject(s) - biology , mycobacterium tuberculosis , cough reflex , in vitro , nociception , tuberculosis , microbiology and biotechnology , mutant , immunology , reflex , receptor , neuroscience , medicine , biochemistry , pathology , gene
Pulmonary tuberculosis, a disease caused by Mycobacterium tuberculosis (Mtb), manifests with a persistent cough as both a primary symptom and mechanism of transmission. The cough reflex can be triggered by nociceptive neurons innervating the lungs, and some bacteria produce neuron-targeting molecules. However, how pulmonary Mtb infection causes cough remains undefined, and whether Mtb produces a neuron-activating, cough-inducing molecule is unknown. Here, we show that an Mtb organic extract activates nociceptive neurons in vitro and identify the Mtb glycolipid sulfolipid-1 (SL-1) as the nociceptive molecule. Mtb organic extracts from mutants lacking SL-1 synthesis cannot activate neurons in vitro or induce cough in a guinea pig model. Finally, Mtb-infected guinea pigs cough in a manner dependent on SL-1 synthesis. Thus, we demonstrate a heretofore unknown molecular mechanism for cough induction by a virulent human pathogen via its production of a complex lipid.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom